|

HAIC + Tislelizumab +lenvatinib Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Chen Xiaoping1

Indications

  • Precision Therapy1
  • HCC1
  • Liver Cancer1
  • Cancer1

Other1 trial

Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.